These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 18087788)
21. Marketing drug information to corporations. Kimelblatt BJ; Kucich JM; Silverman HM; Simon GI Am J Hosp Pharm; 1982 Feb; 39(2):313-4. PubMed ID: 7058808 [No Abstract] [Full Text] [Related]
25. [Drugs and the public--an example of asymmetrical information]. Hanson J Lakartidningen; 2001 Dec; 98(51-52):5922. PubMed ID: 11806273 [No Abstract] [Full Text] [Related]
26. [Guidelines for drug information on the Internet]. Karlsson Y Lakartidningen; 1998 Nov; 95(48):5498. PubMed ID: 9854376 [No Abstract] [Full Text] [Related]
27. [How to improve drug information!]. Järhult B Lakartidningen; 1998 Jul; 95(30-31):3278-9. PubMed ID: 9715057 [No Abstract] [Full Text] [Related]
28. [Written drug advertisements]. Kormeset PO Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1946; author reply 1946-7. PubMed ID: 16915329 [No Abstract] [Full Text] [Related]
29. [The Board for Evaluation of Drug Information: "Cognex clinics" are not popular. Guidelines for a new type of information]. Lakartidningen; 1997 Jan; 94(1-2):32. PubMed ID: 9053600 [No Abstract] [Full Text] [Related]
30. [To listen without wasting time]. Bosnes V Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1195. PubMed ID: 10228428 [No Abstract] [Full Text] [Related]
31. [The inspection of information: "Hidden" comparison, words of evaluation often cause notifications]. Lakartidningen; 1996 Aug; 93(32-33):2763-5. PubMed ID: 8765603 [No Abstract] [Full Text] [Related]
32. [Views on marketing of a neuroleptic agent]. Bendz H Lakartidningen; 1999 Nov; 96(47):5191-2. PubMed ID: 10608107 [No Abstract] [Full Text] [Related]
33. Drug industry's new code criticised for lacking teeth. Coombes R BMJ; 2005 Nov; 331(7527):1225. PubMed ID: 16308367 [No Abstract] [Full Text] [Related]
34. [Health research--industry's point of view]. Dejgaard A; Diderichsen B Ugeskr Laeger; 2003 Jan; 165(4):319-20. PubMed ID: 12599791 [No Abstract] [Full Text] [Related]
35. More on the pharmaceutical quagmire. Schlemmer JP Fam Med; 1993; 25(7):429-30. PubMed ID: 8292144 [No Abstract] [Full Text] [Related]
36. [Reporting by the IGM (Information Inspection Team). Marketing of Clarityn disguised as an inquiry]. Lakartidningen; 1996 Sep; 93(37):3168. PubMed ID: 8847942 [No Abstract] [Full Text] [Related]